Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
Cellosaurus is database indexing available cell lines from various collections: American Type Culture Collection (ATCC), Bioresource Collection and Research Center, Taiwan (BCRC), Banco de Células do Rio de Janeiro (BCRJ), CellBank Australia (CBA), Collection of Cell Lines in Veterinary Medicine (CCLV), Cell Lines Service (CLS), Coriell, Drosophila Genomics Resource Center (DGRC), Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSMZ), European Bank for induced pluripotent Stem Cells (EBiSC), European Collection of Authenticated Cell Cultures (ECACC), Interlab Cell Line Collection (ICLC), Institute for Fermentation Osaka (IFO), Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna (IZSLER) biobank, Japanese Collection of Research Bioresources (JCRB) Cell Bank, Kunming Cell Bank of Type Culture Collection (KCB), Korean Cell Line Bank (KCLB), Millipore, National Cell Bank of Iran (NCBI_Iran), National Cancer Institute - Developmental Therapeutics Program (NCI-DTP), NINDS Human Cell and Data Repository (NHCDR), NIH AIDS Reagent Program (NIH-ARP), NISES, RIKEN Bioresource Center Cell Bank (RCB), Royan Stem Cell Bank (RSCB), Tick Cell Biobank (TCB), Tohoku University cell line catalog (TKG), and Ximbio.
| Name | Proper Citation | Organism | Disease |
Comments |
Defining Citation | Category | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
IMR-32 Resource Report Resource Website 100+ mentions Discontinued Possibly Discontinued |
KCLB Cat# 10127, RRID:CVCL_0346 | Homo sapiens (Human) | Neuroblastoma | Characteristics: Neuroblastic type (N-type)., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:62055 PMID:71759 PMID:327080 PMID:833871 PMID:856461 PMID:922665 PMID:2535691 PMID:3518877 PMID:3698005 PMID:5459762 PMID:6401685 PMID:6888561 PMID:6935474 PMID:7037175 PMID:7139592 PMID:7253718 PMID:7459858 PMID:7838528 PMID:8221663 PMID:8490657 PMID:8665486 PMID:9201287 PMID:9283597 PMID:9516836 PMID:11550280 PMID:11668190 PMID:12210830 PMID:12702577 PMID:15390183 PMID:15892104 PMID:16524757 PMID:16822308 PMID:17974978 PMID:20655465 PMID:22213050 PMID:22460905 PMID:24466371 PMID:25485619 PMID:25877200 PMID:25894527 PMID:26589293 PMID:28350380 PMID:30894373 PMID:31068700 PMID:31581737 PMID:33460449 |
Cancer cell line | Male | IMR 32, IMR32, Institute for Medical Research-32, GM03320, GM3320C, GM03320D, AG03320, AG3320 | KCLB | 10127 | BTO:BTO_0000934, CLO:CLO_0006948, CLO:CLO_0016777, EFO:EFO_0001195, MCCL:MCC:0000242, CLDB:cl2878, CLDB:cl2879, CLDB:cl2880, CLDB:cl2881, CLDB:cl2882, CLDB:cl2883, CLDB:cl2885, CLDB:cl2886, CLDB:cl2887, CLDB:cl2888, ABM:T8975, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ATCC:CCL-127, BCRC:60014, BCRJ:0377, BioGRID_ORCS_Cell_line:637, BioSample:SAMN00808348, BioSample:SAMN03472412, BioSample:SAMN03473082, BioSample:SAMN10988103, cancercelllines:CVCL_0346, CCRID:1101HUM-PUMC000282, CCRID:3101HUMTCHu145, CCRID:4201HUM-CCTCC00107, CCTCC:GDC0107, Cell_Model_Passport:SIDM00226, CGH-DB:78-1, CGH-DB:9095-4, ChEMBL-Cells:CHEMBL3307656, ChEMBL-Targets:CHEMBL614585, CLS:300148, Coriell:AG03320, Coriell:GM03320, Cosmic:688067, Cosmic:759892, Cosmic:801746, Cosmic:920239, Cosmic:922658, Cosmic:947702, Cosmic:1019944, Cosmic:1037352, Cosmic:1099149, Cosmic:1109111, Cosmic:1237544, Cosmic:1518066, Cosmic:1526626, Cosmic:2058113, Cosmic:2131590, Cosmic:2301580, Cosmic:2393630, Cosmic:2485944, DepMap:ACH-000310, DSMZ:ACC-165, DSMZCellDive:ACC-165, ECACC:86041809, EGA:EGAS00001000610, GEO:GSM453632, GEO:GSM563362, GEO:GSM692859, GEO:GSM887162, GEO:GSM888234, GEO:GSM1366406, GEO:GSM1669934, GEO:GSM2371237, GEO:GSM2394364, IARC_TP53:23585, ICLC:HTL96021, IZSLER:BS TCL 29, JCRB:IFO50283, JCRB:JCRB9050, KCB:KCB 2011100YJ, KCLB:10127, LiGeA:CCLE_016, LINCS_LDP:LCL-1965, Lonza:971, PharmacoDB:IMR32_659_2019, PRIDE:PXD000589, Progenetix:CVCL_0346, PubChem_Cell_line:CVCL_0346, RCB:RCB1895, TKG:TKG 0207, Wikidata:Q54897618 |
CVCL_0346 | 2026-09-19 05:41:59 | 353 | ||
|
HBL-100 Resource Report Resource Website 1+ mentions Misidentified Discontinued Discontinued |
RCB Cat# RCB0460, RRID:CVCL_4362 | Homo sapiens (Human) | Karyotypic information: Near triploid with the modal number of 67 chromosomes (ATCC=HTB-124)., Virology: Contains 2 copies of the SV40 genome, one complete the other incomplete tandemly integrated in the cell line genome., Part of: JWGray breast cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line from a 27 year old Caucasian woman. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.. |
PMID:2547730 PMID:2840847 PMID:2995096 PMID:3109929 PMID:6500159 PMID:6891286 PMID:9671407 PMID:10969801 PMID:11416159 PMID:12661003 PMID:16643607 PMID:17157791 PMID:20143388 PMID:24094812 PMID:24176112 PMID:25485619 PMID:25877200 PMID:26589293 PMID:28889351 |
Transformed cell line | Male | HBL 100, HBL100 | RCB | RCB0460 | BTO:BTO_0004734, CLO:CLO_0003626, EFO:EFO_0001167, CLDB:cl1571, ArrayExpress:E-MTAB-2706, ArrayExpress:E-TABM-157, ATCC:HTB-124, BioSample:SAMN03152011, BioSample:SAMN03471101, BioSample:SAMN03472914, CCRID:1101HUM-PUMC000374, CCRID:3101HUMGNHu10, CCTCC:GDC0195, ChEMBL-Cells:CHEMBL3307713, ChEMBL-Targets:CHEMBL614811, CLS:300178, Cosmic:687471, Cosmic:877447, Cosmic:934533, Cosmic:979722, Cosmic:991323, Cosmic:1010933, Cosmic:1136364, Cosmic:1176632, Cosmic:1434949, Cosmic:1524348, Cosmic:1609469, DepMap:ACH-002321, EGA:EGAS00001000610, GEO:GSM1053697, IARC_TP53:21063, LINCS_HMS:51117, PharmacoDB:HBL100_443_2019, PubChem_Cell_line:CVCL_4362, RCB:RCB0460, TOKU-E:3589, Ubigene:YC-C013, Wikidata:Q54881428 |
CVCL_4362 | 2026-09-19 05:35:13 | 2 | |||
|
HBL-100 Resource Report Resource Website 1+ mentions Misidentified Discontinued Discontinued |
CCTCC Cat# GDC0195, RRID:CVCL_4362 | Homo sapiens (Human) | Karyotypic information: Near triploid with the modal number of 67 chromosomes (ATCC=HTB-124)., Virology: Contains 2 copies of the SV40 genome, one complete the other incomplete tandemly integrated in the cell line genome., Part of: JWGray breast cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misidentified. Presence of a Y chromosome in cell line that was thought to be of female origin (PubMed=16643607; PubMed=20143388). Originally thought to originate from a casein-producing breast cell line from a 27 year old Caucasian woman. In addition contains SV40 genomic sequence while the cell line was deemed to be spontaneously immortalized.. |
PMID:2547730 PMID:2840847 PMID:2995096 PMID:3109929 PMID:6500159 PMID:6891286 PMID:9671407 PMID:10969801 PMID:11416159 PMID:12661003 PMID:16643607 PMID:17157791 PMID:20143388 PMID:24094812 PMID:24176112 PMID:25485619 PMID:25877200 PMID:26589293 PMID:28889351 |
Transformed cell line | Male | HBL 100, HBL100 | CCTCC | GDC0195 | BTO:BTO_0004734, CLO:CLO_0003626, EFO:EFO_0001167, CLDB:cl1571, ArrayExpress:E-MTAB-2706, ArrayExpress:E-TABM-157, ATCC:HTB-124, BioSample:SAMN03152011, BioSample:SAMN03471101, BioSample:SAMN03472914, CCRID:1101HUM-PUMC000374, CCRID:3101HUMGNHu10, CCTCC:GDC0195, ChEMBL-Cells:CHEMBL3307713, ChEMBL-Targets:CHEMBL614811, CLS:300178, Cosmic:687471, Cosmic:877447, Cosmic:934533, Cosmic:979722, Cosmic:991323, Cosmic:1010933, Cosmic:1136364, Cosmic:1176632, Cosmic:1434949, Cosmic:1524348, Cosmic:1609469, DepMap:ACH-002321, EGA:EGAS00001000610, GEO:GSM1053697, IARC_TP53:21063, LINCS_HMS:51117, PharmacoDB:HBL100_443_2019, PubChem_Cell_line:CVCL_4362, RCB:RCB0460, TOKU-E:3589, Ubigene:YC-C013, Wikidata:Q54881428 |
CVCL_4362 | 2026-09-19 05:35:13 | 2 | |||
|
HCA7 Resource Report Resource Website 1+ mentions |
RRID:CVCL_0289 | Homo sapiens (Human) | Colon adenocarcinoma | Part of: KuDOS 95 cell line panel. |
PMID:3718830 PMID:4016751 PMID:8410493 PMID:8464898 PMID:9294210 PMID:10737795 PMID:11226274 PMID:16418264 PMID:18258742 PMID:20570890 PMID:20606684 PMID:24755471 PMID:25485619 PMID:25877200 PMID:25926053 PMID:26589293 PMID:29101300 |
Cancer cell line | Female | HCA-7, HCA 7 | BTO:BTO_0003031, EFO:EFO_0006415, MCCL:MCC:0000179, AddexBio:C0009003/40, ArrayExpress:E-MTAB-2706, BioSample:SAMN03471988, cancercelllines:CVCL_0289, ColonAtlas:HCA7, Cosmic:876722, Cosmic:948860, Cosmic:985995, Cosmic:995407, Cosmic:1043813, Cosmic:1223140, Cosmic:1312301, Cosmic:1479629, Cosmic:1486131, Cosmic:1805252, Cosmic:1933017, Cosmic:2301976, Cosmic:2760084, ECACC:06061902, EGA:EGAS00001000610, GEO:GSM741260, GEO:GSM1346872, GEO:GSM1374491, GEO:GSM1374492, GEO:GSM1448125, GEO:GSM3145609, GEO:GSM3145708, IARC_TP53:21760, PharmacoDB:HCA7_445_2019, PRIDE:PXD005354, PRIDE:PXD005355, Wikidata:Q54881491, Ximbio:152451 |
CVCL_0289 | 2026-09-19 05:35:15 | 4 | ||||
|
HMCB Resource Report Resource Website 1+ mentions |
RRID:CVCL_3317 | Homo sapiens (Human) | Melanoma | Caution: The exact relationship between HMCB (Cellosaurus=CVCL_3317) and RPMI-7262/7272/7932/7962/7972 is not clear: all are derived from patient 'Bowes' melanoma., Anecdotal: The Bowes cell line is famous for its use in the identification and purification of tissue-type plasminogen activator, tPA., Population: Caucasian., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line. |
PMID:1970678 PMID:12068308 PMID:20215515 PMID:22460905 PMID:26589293 PMID:30894373 PMID:31068700 |
Cancer cell line | Female | Human Melanoma Cell Bowes, Bowes melanoma cells, BOWES | BTO:BTO_0001998, CLO:CLO_0003785, EFO:EFO_0002195, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-2770, ATCC:CRL-9607, BioSample:SAMN10988240, cancercelllines:CVCL_3317, Cell_Model_Passport:SIDM00914, ChEMBL-Cells:CHEMBL3308385, ChEMBL-Targets:CHEMBL614824, Cosmic:724822, DepMap:ACH-000931, GEO:GSM827473, GEO:GSM887087, GEO:GSM888157, IARC_TP53:21374, IGRhCellID:HMCB, LiGeA:CCLE_295, NCBI_Iran:C524, PharmacoDB:HMCB_553_2019, Progenetix:CVCL_3317, PubChem_Cell_line:CVCL_3317, Wikidata:Q54889913 |
CVCL_3317 | 2026-09-19 05:38:02 | 9 | ||||
|
HOP-62 Resource Report Resource Website 10+ mentions |
RRID:CVCL_1285 | Homo sapiens (Human) | Lung adenocarcinoma | Population: Caucasian., Part of: NCI-60 cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:2041050 PMID:2388294 PMID:2536293 PMID:9331090 PMID:10700174 PMID:12068308 PMID:15748285 PMID:17088437 PMID:19372543 PMID:20164919 PMID:22068913 PMID:22347499 PMID:22384151 PMID:22628656 PMID:22961666 PMID:23856246 PMID:23933261 PMID:24279929 PMID:24670534 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27377824 PMID:27397505 PMID:27807467 PMID:28196595 PMID:29681454 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31733513 PMID:35839778 PMID:38861359 |
Cancer cell line | Female | HOP 62, Hop 62, HOP.62, HOP62, Hop62, Hopkins-62 | BTO:BTO_0004080, CLO:CLO_0037016, EFO:EFO_0006439, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:418, BioSample:SAMN03471402, BioSample:SAMN10989587, cancercelllines:CVCL_1285, Cell_Model_Passport:SIDM00133, ChEMBL-Cells:CHEMBL3307671, ChEMBL-Targets:CHEMBL614643, Cosmic:875855, Cosmic:905972, Cosmic:974289, Cosmic:1092603, Cosmic:1146945, Cosmic:1175861, Cosmic:1305344, Cosmic:1995442, Cosmic:1998445, Cosmic-CLP:905972, DepMap:ACH-000861, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:905972, GEO:GSM2105, GEO:GSM50211, GEO:GSM50274, GEO:GSM206507, GEO:GSM274784, GEO:GSM274816, GEO:GSM434275, GEO:GSM743450, GEO:GSM750804, GEO:GSM794404, GEO:GSM799338, GEO:GSM799401, GEO:GSM846357, GEO:GSM1153408, GEO:GSM1178204, GEO:GSM1178205, GEO:GSM1178206, GEO:GSM1181256, GEO:GSM1181314, GEO:GSM1374542, GEO:GSM2124640, IARC_TP53:21113, IGRhCellID:HOP-62_02GEO, LiGeA:CCLE_548, LINCS_LDP:LCL-1666, NCI-DTP:HOP-62, PharmacoDB:HOP62_561_2019, PRIDE:PXD003539, PRIDE:PXD005942, PRIDE:PXD005946, PRIDE:PXD030304, Progenetix:CVCL_1285, PubChem_Cell_line:CVCL_1285, SKY/M-FISH/CGH:2896, Wikidata:Q54890155 |
CVCL_1285 | 2026-09-19 05:38:07 | 11 | ||||
|
HPAF-II Resource Report Resource Website 50+ mentions |
RRID:CVCL_0313 | Homo sapiens (Human) | Pancreatic ductal adenocarcinoma | Caution: TP53 mutation indicated incorrectly as being at c.452C>T in PubMed=1764370., Caution: Could not find proof that the CD18 subline of HPAF is really HPAF-II but many indirect evidences points in this direction. If someone read this comment and can help us, please do., Population: Caucasian., Part of: NCI RAS program mutant KRAS cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:1764370 PMID:2734279 PMID:11787853 PMID:12068308 PMID:12692724 PMID:15126341 PMID:15367885 PMID:15367897 PMID:18380791 PMID:20164919 PMID:20215515 PMID:20418756 PMID:22460905 PMID:22585861 PMID:25485619 PMID:25877200 PMID:25984343 PMID:26216984 PMID:26589293 PMID:27259358 PMID:27397505 PMID:28196595 PMID:29444439 PMID:30894373 PMID:30971826 PMID:31037374 PMID:31068700 |
Cancer cell line | Male | HPAF II, HPAFII, HPAF-2, HPAF2, HPAF/CD18, CD18/HPAF, HPAF-II/CD18, CD-18, CD18, CD 18 | BTO:BTO_0003266, CLO:CLO_0003816, EFO:EFO_0002198, MCCL:MCC:0000206, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ATCC:CRL-1997, BioGRID_ORCS_Cell_line:236, BioSample:SAMN03471950, BioSample:SAMN10987875, cancercelllines:CVCL_0313, CCRID:3101HUMSCSP5011, Cell_Model_Passport:SIDM00669, CGH-DB:165-1, CGH-DB:9274-4, ChEMBL-Cells:CHEMBL3308744, ChEMBL-Targets:CHEMBL1075467, CLS:305088, Cosmic:710858, Cosmic:724869, Cosmic:868241, Cosmic:913304, Cosmic:922247, Cosmic:1108343, Cosmic:1299299, Cosmic:1320467, Cosmic:1571777, Cosmic:2046534, Cosmic:2434099, Cosmic-CLP:724869, DepMap:ACH-000094, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:724869, GEO:GSM206510, GEO:GSM385517, GEO:GSM385528, GEO:GSM621899, GEO:GSM784696, GEO:GSM827289, GEO:GSM887090, GEO:GSM888161, GEO:GSM1024402, GEO:GSM1374546, GEO:GSM1374547, GEO:GSM1669893, IARC_TP53:944, IGRhCellID:HPAFII, IZSLER:BS TCL 170, LiGeA:CCLE_028, LINCS_LDP:LCL-1736, MetaboLights:MTBLS812, PharmacoDB:HPAFII_565_2019, PRIDE:PXD003198, Progenetix:CVCL_0313, PubChem_Cell_line:CVCL_0313, TOKU-E:4028, Wikidata:Q54890231 |
cvcl_b284 | CVCL_0313 | 2026-09-19 05:38:09 | 71 | |||
|
HPB-ALL Resource Report Resource Website 1+ mentions |
RRID:CVCL_1820 | Homo sapiens (Human) | Childhood T acute lymphoblastic leukemia | Population: Japanese., Part of: LL-100 blood cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:203546 PMID:1373528 PMID:2140233 PMID:2985879 PMID:3159941 PMID:3874327 PMID:6181032 PMID:6582512 PMID:6749281 PMID:8127147 PMID:8641406 PMID:8957066 PMID:9510473 PMID:9738977 PMID:9933131 PMID:10739008 PMID:11226526 PMID:12661009 PMID:15472075 PMID:16142349 PMID:17170727 PMID:22460905 PMID:22675565 PMID:26589293 PMID:30285677 PMID:30629668 PMID:30894373 PMID:31068700 PMID:31160637 PMID:35354797 |
Cancer cell line | Male | HPB/ALL, HPBALL, FCCH1018 | BTO:BTO_0001952, CLO:CLO_0003817, CLO:CLO_0050988, EFO:EFO_0022458, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, BioSample:SAMN01821632, BioSample:SAMN03473562, BioSample:SAMN10988462, cancercelllines:CVCL_1820, Cell_Model_Passport:SIDM01618, ChEMBL-Cells:CHEMBL4295419, ChEMBL-Targets:CHEMBL4296435, Cosmic:801726, Cosmic:913406, Cosmic:919159, Cosmic:933550, Cosmic:998736, Cosmic:999754, Cosmic:1037689, Cosmic:1115583, Cosmic:1130235, Cosmic:1151779, Cosmic:1224373, Cosmic:1281368, Cosmic:1330499, Cosmic:1524796, Cosmic:1641378, Cosmic:1664521, Cosmic:1760522, Cosmic:2165711, Cosmic:2602914, DepMap:ACH-000942, DSMZ:ACC-483, DSMZCellDive:ACC-483, FANTOM5_SSTAR:10429-106D6, GEO:GSM887091, GEO:GSM888162, GEO:GSM5137717, IARC_TP53:21703, LiGeA:CCLE_898, Lonza:250, NCBI_Iran:C213, PharmacoDB:HPBALL_566_2019, PRIDE:PXD023662, Progenetix:CVCL_1820, PubChem_Cell_line:CVCL_1820, RCB:RCB1935, TKG:TKG 0199, Wikidata:Q54890235 |
CVCL_1820 | 2026-09-19 05:38:09 | 7 | ||||
|
HL-60 Resource Report Resource Website 1000+ mentions Discontinued |
RRID:CVCL_0002 | Homo sapiens (Human) | Adult acute myeloid leukemia with maturation | Anecdotal: Established at the 60th attempt to culture human leukemia biopsies in Gallo's lab. All the preceding attempts having failed., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Biotechnology: Used a source of mitochondrial DNA for USA forensic testing., Population: Caucasian., Part of: MYC genetic alteration cell panel (ATCC TCP-1035)., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut). |
PMID:271272 PMID:288488 PMID:1368402 PMID:1574572 PMID:1970118 PMID:2140233 PMID:2545346 PMID:2858093 PMID:2985879 PMID:3159941 PMID:3311197 PMID:3335022 PMID:3422031 PMID:3860286 PMID:3874327 PMID:6091813 PMID:6255959 PMID:6582512 PMID:6945469 PMID:6954533 PMID:6996765 PMID:7630190 PMID:8316623 PMID:8343448 PMID:8558913 PMID:8562479 PMID:9434637 PMID:9510473 PMID:9557624 PMID:9607592 PMID:9737686 PMID:9738977 PMID:10739008 PMID:11226526 PMID:11416159 PMID:12068308 PMID:12661003 PMID:15843827 PMID:16120335 PMID:16408098 PMID:16957166 PMID:17088437 PMID:20164919 PMID:20215515 PMID:22032829 PMID:22068913 PMID:22347499 PMID:22460905 PMID:22944676 PMID:23955599 PMID:24368162 PMID:24670534 PMID:25485619 PMID:25877200 PMID:25894527 PMID:25984343 PMID:26589293 PMID:27397505 PMID:28109323 PMID:28196595 PMID:29491412 PMID:30285677 PMID:30629668 PMID:30670178 PMID:30894373 PMID:31068700 PMID:31160637 PMID:31733513 PMID:33389257 PMID:35839778 PMID:36982453 |
Cancer cell line | Female | HL 60, HL.60, HL60, Human Leukemia-60 | BTO:BTO_0000738, CLO:CLO_0003775, CLO:CLO_0050972, EFO:EFO_0002793, MCCL:MCC:0000195, CLDB:cl1682, CLDB:cl1684, CLDB:cl1685, CLDB:cl1686, CLDB:cl1687, CLDB:cl1688, CLDB:cl1689, CLDB:cl1690, CLDB:cl1691, CLDB:cl1693, Abcam:ab282204, AddexBio:C0003023/4977, ArrayExpress:E-MTAB-38, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, ArrayExpress:E-MTAB-7721, ArrayExpress:E-MTAB-7722, ATCC:CCL-240, BCRC:60027, BCRJ:0104, BioGRID_ORCS_Cell_line:42, BioSample:SAMN01821559, BioSample:SAMN01821682, BioSample:SAMN03472768, BioSample:SAMN03473174, BioSample:SAMN10988245, cancercelllines:CVCL_0002, CCRID:1101HUM-PUMC000037, CCRID:1102HUM-NIFDC00098, CCRID:3101HUMTCHu23, CCRID:4201HUM-CCTCC00028, CCTCC:GDC0027, CCTCC:GDC0028, Cell_Model_Passport:SIDM00829, ChEMBL-Cells:CHEMBL3307654, ChEMBL-Targets:CHEMBL383, CLS:300209, Cosmic:716179, Cosmic:716190, Cosmic:724817, Cosmic:787433, Cosmic:798224, Cosmic:798665, Cosmic:808506, Cosmic:821043, Cosmic:850380, Cosmic:851996, Cosmic:875866, Cosmic:905938, Cosmic:919116, Cosmic:922161, Cosmic:922683, Cosmic:924049, Cosmic:932769, Cosmic:947366, Cosmic:949099, Cosmic:975252, Cosmic:981578, Cosmic:991557, Cosmic:994170, Cosmic:999724, Cosmic:1012068, Cosmic:1019836, Cosmic:1037661, Cosmic:1070693, Cosmic:1078724, Cosmic:1089519, Cosmic:1092602, Cosmic:1107177, Cosmic:1127250, Cosmic:1130234, Cosmic:1168468, Cosmic:1176580, Cosmic:1181599, Cosmic:1191695, Cosmic:1192826, Cosmic:1226863, Cosmic:1281315, Cosmic:1305337, Cosmic:1308224, Cosmic:1319549, Cosmic:1451845, Cosmic:1465966, Cosmic:1523825, Cosmic:1524830, Cosmic:1582390, Cosmic:1601062, Cosmic:1604861, Cosmic:1998444, Cosmic:2036678, Cosmic:2089652, Cosmic:2131539, Cosmic:2301565, Cosmic:2306208, Cosmic:2651387, Cosmic-CLP:905938, DepMap:ACH-000002, DSMZ:ACC-3, DSMZCellDive:ACC-3, ECACC:98070106, EGA:EGAS00001000610, EGA:EGAS00001000978, ENCODE:ENCBS069ENC, ENCODE:ENCBS070ENC, ENCODE:ENCBS215JQI, ENCODE:ENCBS308XSW, ENCODE:ENCBS373UEY, ENCODE:ENCBS482VCU, ENCODE:ENCBS698WLF, ENCODE:ENCBS869DKF, ENCODE:ENCBS880XNW, FANTOM5_SSTAR:10829-111D1, GDSC:905938, GEO:GSM50194, GEO:GSM50258, GEO:GSM213809, GEO:GSM236782, GEO:GSM236818, GEO:GSM472908, GEO:GSM472942, GEO:GSM482507, GEO:GSM545496, GEO:GSM545497, GEO:GSM743458, GEO:GSM749688, GEO:GSM749775, GEO:GSM750812, GEO:GSM799346, GEO:GSM799409, GEO:GSM838428, GEO:GSM838429, GEO:GSM838430, GEO:GSM838431, GEO:GSM887083, GEO:GSM888153, GEO:GSM945222, GEO:GSM945255, GEO:GSM1153417, GEO:GSM1181331, GEO:GSM1181348, GEO:GSM1374535, GEO:GSM1374536, GEO:GSM1446736, GEO:GSM1669883, GEO:GSM2716740, GEO:GSM2716741, GEO:GSM2716742, GEO:GSM2716743, GEO:GSM7701378, GEO:GSM7701379, IARC_TP53:21372, IARC_TP53:21731, ICLC:HTL95010, IGRhCellID:HL60, IZSLER:BS TCL 25, JCRB:IFO50022, JCRB:JCRB0085, JCRB:NIHS0086, KCB:KCB 2014051YJ, KCLB:10240, LiGeA:CCLE_789, LINCS_LDP:LCL-1054, Lonza:64, MeSH:D018922, NCBI_Iran:C217, PharmacoDB:HL60_546_2019, PRIDE:PRD000345, PRIDE:PXD000589, PRIDE:PXD003539, PRIDE:PXD006421, PRIDE:PXD030304, PRIDE:PXD032942, Progenetix:CVCL_0002, PubChem_Cell_line:CVCL_0002, RCB:RCB0041, RCB:RCB3683, SKY/M-FISH/CGH:5609, TKG:TKG 0345, TOKU-E:1488, Ubigene:YC-C058, Wikidata:Q5630035 |
CVCL_0002 | 2026-09-19 05:37:59 | 4410 | ||||
|
HLF Resource Report Resource Website 10+ mentions |
RRID:CVCL_2947 | Homo sapiens (Human) | Adult hepatocellular carcinoma | Population: Japanese., Part of: MD Anderson Cell Lines Project., Part of: Liver Cancer Model Repository (LIMORE)., Part of: JFCR45 cancer cell line panel., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:52570 PMID:1778766 PMID:7874267 PMID:8389256 PMID:9290701 PMID:10523694 PMID:12029633 PMID:15767549 PMID:22460905 PMID:23505090 PMID:23887712 PMID:25984343 PMID:26589293 PMID:28196595 PMID:30894373 PMID:31063779 PMID:31068700 PMID:31378681 PMID:31978347 PMID:32899426 |
Cancer cell line | Male | CLO:CLO_0009987, ArrayExpress:E-MTAB-2770, BioGRID_ORCS_Cell_line:657, BioSample:SAMN10987769, cancercelllines:CVCL_2947, Cell_Model_Passport:SIDM00065, CGH-DB:9076-4, Cosmic:945157, Cosmic:1187332, Cosmic:1518229, Cosmic:2023860, Cosmic:2162527, DepMap:ACH-000393, GEO:GSM887086, GEO:GSM888156, GEO:GSM936758, GEO:GSM1374538, GEO:GSM1669885, GEO:GSM2551567, IARC_TP53:2009, JCRB:JCRB0405, LiGeA:CCLE_520, LIMORE:HLF, LINCS_HMS:50015, LINCS_LDP:LCL-1938, PharmacoDB:HLF_549_2019, Progenetix:CVCL_2947, Wikidata:Q54889850 |
CVCL_2947 | 2026-09-19 05:38:00 | 14 | |||||
|
HGC-27 Resource Report Resource Website 500+ mentions |
RRID:CVCL_1279 | Homo sapiens (Human) | Gastric carcinoma | Population: Japanese., Part of: JFCR45 cancer cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:136873 PMID:3986962 PMID:11314020 PMID:11416159 PMID:15767549 PMID:15901131 PMID:20164919 PMID:20215515 PMID:22460905 PMID:24807215 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:30894373 PMID:30971826 PMID:31068700 PMID:31978347 PMID:34466148 PMID:35839778 |
Cancer cell line | Sex unspecified | HGC 27, HGC27 | BTO:BTO_0004828, CLO:CLO_0003739, CLO:CLO_0050799, EFO:EFO_0006581, CLDB:cl1673, CLDB:cl1674, ArrayExpress:E-MTAB-783, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-2770, ArrayExpress:E-MTAB-3610, BCRJ:0310, BioGRID_ORCS_Cell_line:658, BioSample:SAMN03472940, BioSample:SAMN10987863, cancercelllines:CVCL_1279, CCRID:1101HUM-PUMC000279, CCRID:3101HUMTCHu22, CCRID:5301HUM-KCB16001YJ, Cell_Model_Passport:SIDM00290, ChEMBL-Cells:CHEMBL3308741, ChEMBL-Targets:CHEMBL1075463, CLS:300436, Cosmic:907055, Cosmic:1001653, Cosmic:1007604, Cosmic:1187274, Cosmic:1518247, Cosmic:1995440, Cosmic:2484952, Cosmic:2807625, Cosmic-CLP:907055, DepMap:ACH-000847, ECACC:94042256, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:907055, GEO:GSM552358, GEO:GSM827366, GEO:GSM844558, GEO:GSM887081, GEO:GSM888151, GEO:GSM1374533, GEO:GSM1374534, GEO:GSM1669881, GEO:GSM2983069, GEO:GSM2983070, GEO:GSM2983071, GEO:GSM2983072, IARC_TP53:21370, ICLC:HTL95028, KCB:KCB 2016001YJ, LiGeA:CCLE_106, LINCS_LDP:LCL-1882, PharmacoDB:HGC27_543_2019, PRIDE:PXD030304, Progenetix:CVCL_1279, PubChem_Cell_line:CVCL_1279, RCB:RCB0500, Ubigene:YC-C079, Wikidata:Q54886004 |
CVCL_1279 | 2026-09-19 05:37:28 | 586 | ||||
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
IZSLER Cat# BS TCL 23, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | IZSLER | BS TCL 23 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-09-19 05:35:50 | 2898 | |
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
ATCC Cat# CCL-23, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | ATCC | CCL-23 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-09-19 05:35:50 | 2898 | |
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
ECACC Cat# 86030501, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | ECACC | 86030501 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-09-19 05:35:50 | 2898 | |
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
KCLB Cat# 10023, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | KCLB | 10023 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-09-19 05:35:50 | 2898 | |
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
CCLV Cat# CCLV-RIE 0141, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | CCLV | CCLV-RIE 0141 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-09-19 05:35:50 | 2898 | |
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
BCRC Cat# 60042, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | BCRC | 60042 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-09-19 05:35:50 | 2898 | |
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
BCRJ Cat# 0101, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | BCRJ | 0101 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-09-19 05:35:50 | 2898 | |
|
HEp-2 Resource Report Resource Website 1000+ mentions Contaminated Discontinued |
CCTCC Cat# GDC0004, RRID:CVCL_1906 | Homo sapiens (Human) | Human papillomavirus-related endocervical adenocarcinoma | Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Population: African American., Part of: KuDOS 95 cell line panel., Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=4864103; PubMed=5641128; PubMed=566722; PubMed=1246601; PubMed=20143388). Originally thought to originate from a 56 year old male patient with a laryngeal carcinoma.. |
PMID:566722 PMID:1246601 PMID:3180844 PMID:4203458 PMID:4864103 PMID:5641128 PMID:5668122 PMID:6988327 PMID:8397027 PMID:11416159 PMID:13209540 PMID:13261081 PMID:14185313 PMID:17254797 PMID:19450234 PMID:19941903 PMID:20143388 PMID:23925245 PMID:25485619 PMID:26589293 PMID:29483928 PMID:29967540 PMID:31105993 PMID:33389257 PMID:34024160 PMID:34697958 |
Cancer cell line | Female | Hep-2, HEP-2, Hep2 (HeLa derivative), HEp-2/HeLa, Hep 2, Hep2, HEp2, HEP2, H.Ep.-2, H.Ep. #2, H.Ep. No. 2, Hep II, Human Epidermoid carcinoma #2, Human Epithelioma-2 | CCTCC | GDC0004 | BTO:BTO_0000976, CLO:CLO_0003706, CLO:CLO_0003707, CLO:CLO_0050927, EFO:EFO_0006438, CLDB:cl1646, CLDB:cl1647, CLDB:cl1649, CLDB:cl1650, CLDB:cl1653, CLDB:cl1654, CLDB:cl1655, AddexBio:C0050001/4983, ArrayExpress:E-MTAB-2706, ATCC:CCL-23, BCRC:60042, BCRJ:0101, BioSample:SAMN03151706, CCLV:CCLV-RIE 0141, CCRID:1101HUM-PUMC000068, CCRID:4201PAT-CCTCC00214, CCTCC:GDC0004, Cell_Model_Passport:SIDM01208, ChEMBL-Cells:CHEMBL3307694, ChEMBL-Targets:CHEMBL614735, CLS:300397, Cosmic:1339928, Cosmic:1530739, Cosmic:1969495, Cosmic:2301559, ECACC:86030501, EGA:EGAS00001000610, FANTOM5_SSTAR:11890-125D9, FANTOM5_SSTAR:11891-125E1, FANTOM5_SSTAR:11892-125E2, FANTOM5_SSTAR:11894-125E4, FANTOM5_SSTAR:11895-125E5, FANTOM5_SSTAR:11896-125E6, FANTOM5_SSTAR:11898-125E8, FANTOM5_SSTAR:11899-125E9, FANTOM5_SSTAR:11900-125F1, GEO:GSM1374529, GEO:GSM1374530, IZSLER:BS TCL 23, KCLB:10023, NCBI_Iran:C144, PharmacoDB:HEp2_540_2019, PRIDE:PXD006201, PRIDE:PXD013072, PRIDE:PXD014913, PRIDE:PXD031726, PubChem_Cell_line:CVCL_1906, RCB:RCB1889, TKG:TKG 0403, TOKU-E:1442, Wikidata:Q16554737 |
cvcl_0030 | CVCL_1906 | 2026-09-19 05:35:50 | 2898 | |
|
HEY Resource Report Resource Website 10+ mentions |
RRID:CVCL_0297 | Homo sapiens (Human) | High grade ovarian serous adenocarcinoma | Population: Caucasian., Part of: MD Anderson Cell Lines Project., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE). |
PMID:3731068 PMID:4016745 PMID:12960427 PMID:19926575 PMID:20204287 PMID:22710073 PMID:23415752 PMID:24023729 PMID:25485619 PMID:25877200 PMID:26589293 PMID:27397505 PMID:28196595 PMID:30485824 PMID:30894373 PMID:30971826 PMID:35839778 |
Cancer cell line | Female | Hey | BTO:BTO_0002590, EFO:EFO_0006580, MCCL:MCC:0000188, ArrayExpress:E-MTAB-2706, ArrayExpress:E-MTAB-3610, BioGRID_ORCS_Cell_line:866, BioSample:SAMN03473280, cancercelllines:CVCL_0297, Cell_Model_Passport:SIDM00968, ChEMBL-Cells:CHEMBL3308082, ChEMBL-Targets:CHEMBL613869, CLS:305017, Cosmic:1102812, Cosmic:1524358, Cosmic-CLP:1479988, DepMap:ACH-002140, EGA:EGAS00001000610, EGA:EGAS00001000978, GDSC:1479988, GEO:GSM659377, GEO:GSM1340581, GEO:GSM1669880, IARC_TP53:28489, PharmacoDB:HEY_541_2019, PRIDE:PXD030304, PubChem_Cell_line:CVCL_0297, Wikidata:Q54883211 |
cvcl_4995 | CVCL_0297 | 2026-09-19 05:36:06 | 23 |
Can't find your Cell Line?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. If you want to find a specific cell line, it's easier to enter an RRID or add the vendor information to search. You can refine the search results using Facets on the left side of the search results page. If you are on the table view, you can also search in a specific column by clicking the column title and enter the keywords.
If you still could not find your cell line in the search results, please help us by registering it into the system — it's easy. Register it with the Cellosaurus. An RRID will be generated in 1-2 business days.
Welcome to the NIF Resources search. From here you can search through a compilation of resources used by NIF and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that NIF has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on NIF then you can log in from here to get additional features in NIF such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into NIF you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.